Skip to main content
. 2007 Mar 12;75(6):2853–2863. doi: 10.1128/IAI.01045-06

TABLE 2.

Gene expression data in microarray for the 19 selected probe sets

Homo sapiens gene or gene product Probe set Accession no. Mean change (n-fold) vs. mock (n = 2)a
24 h Cpn 24 h Cpn + IFN-γ 96 h Cpn + IFN-γ
2′-5′oligoadenylate synthetase-like (OASL) 205660_at NM_198213 NC I (5.2/5.5) I (1.9/3.7)
2′-5′oligoadenylate synthetase-like (OASL) 210797_s_at NM_198213 NC I (5.6/6.2) I (2.2/3.0)
Adlican 209596_at AF245505.1 D (1.7/1.8) D (NC/1.5) D (3.5/3.2)
BCL2 adenovirus E1B 19-kDa interacting protein 3 (BNIP3) 221478_at NM_004052 D (2.6/2.1) D (2.2/1.8) D (2.8/2.6)
BCL2 adenovirus E1B 19-kDa interacting protein 3 (BNIP3) 201848_s_at NM_004052 D (3.4/1.5) NC D (3.0/3.3)
Carbonic anhydrase IX (CA9) 205199_at NM_001216 D (2.3/2.2) D (NC/1.8) D (15.6/7.9)
Cystathionase (cystathionine gamma-lyase) (CTH) 206085_s_at NM_001902 D (1.2/1.1) D (4.5/2.9) D (NC/1.8)
Cystathionase (cystathionine gamma-lyase) (CTH) 217127_at NM_001902 D (2.1/1.3) D (5.7/3.9) D (NC/1.3)
Cysteine-rich, angiogenic inducer, 61 (CYR61) 210764_s_at AF003114.1 I (5.7/4.1) I (2.5/1.8) I (1.6/NC)
Dapper homolog 1 (DACT1) 219179_at NM_016651 NC D (1.9/2.7) D (2.9/2.5)
Dickkopf (Xenopus laevis) homolog 1 (DKK1) 204602_at NM_012242 I (4.0/4.2) I (2.5/2.4) I (3.5/4.1)
Hairy/enhancer-of-split related with YRPW motif 1 (HEY1) 44783_s_at NM_012258 D (4.2/3.7) D (4.9/5.7) D (1.4/NC)
Heat shock 70-kDa protein 1A (HSPA1A) 200799_at NM_005345 NC I (10.3/7.3) D (2.0/1.7)
Heat shock 70-kDa protein 1A (HSPA1A) 200800_s_at NM_005345 NC I (14.4/11.8) D (1.6/1.7)
Heat shock 70-kDa protein 1B (HSPA1B) 202581_at NM_005346 D (NC/1.5) I (13.6/9.0) D (NC/1.7)
Insulin-induced gene 1 (INSIG1) 201626_at NM_005542 D (3.9/3.2) D (2.3/1.9) D (1.8/3.5)
Insulin-induced gene 1 (INSIG1) 201627_s_at NM_005542 D (3.0/3.8) D (2.6/2.3) NC
Interferon-induced, hepatitis C-associated microtubular aggregate protein (44 kDa) (MTAP44 or IFI44) 214453_s_at NM_006417 I (1.7/NC) I (5.4/5.0) I (2.4/3.8)
Interferon-induced, hepatitis C-associated microtubular aggregate protein (44 kDa) (MTAP44 or IFI44) 214059_at NM_006417 NC I (3.3/4.4) NC
Keratin 17 (KRT17) 212236_x_at NM_000422 I (2.1/2.0) I (1.9/2.0) D (3.5/3.9)
Keratin 17 (KRT17) 205157_s_at NM_000422 I (2.4/2.0) I (1.6/.03) D (3.0/5.4)
Lysyl oxidase (LOX) gene 215446_s_at L16895 D (2.1/2.3) D (2.5/2.1) D (4.2/3.6)
N-myc downstream regulated (NDRG1) 200632_s_at NM_006096 D (4.1/2.2) D (3.0/2.1) D (7.1/4.1)
Prostaglandin E receptor 4 (subtype EP4) (PTGER4) 204897_at NM_000958 I (2.2/2.0) I (2.4/2.3) I (2.8/3.9)
Retinoic acid induced 3 (RAI3) 203108_at NM_003979 I (3.8/2.7) I (2.8/3.4) I (2.0/1.5)
Serum-inducible kinase (SNK) or polo-like kinase 2 (PLK2) 201939_at NM_006622 I (2.4/4.2) NC I (3.7/4.8)
a

Altered gene expression data for selected Affymetrix HG-U133A probe sets. All 19 genes were selected for real-time two-step RT-PCR analysis. Expression changes between two arrays are designated “change (n-fold)” (treatment versus mock treatment at the corresponding time point). Depicted are the changes (D, decrease; I, increase; NC, no change) in two independent microarray experiments of C. pneumoniae-infected HeLa-cells (24 h Cpn = productive infection) in the IFN-γ persistence model (24 h and 96 h Cpn + IFN-γ). All selected genes had signal log ratios greater than 1.32 or lower than −1.32 (α1 = 0.05; α2 = 0.065; τ = 0.015) under at least one experimental condition and present calls in both samples.